Follow Blog via Email
Join 2,132 other subscribersDCIS 411 Facebook page
-
Follow @dcis411 on INSTAGRAM
Follow @dcis411 on X
My Tweets-
Recent Posts
- Women in Online DCIS Support Group Say “NO” to the “C” Word, “NO” to “Standard of Care” Overtreatment, and Yes to Healthy Lifestyle — New Research Study!
- In 2011, My Doctor Told Me: “Your Breast is Like Spoiled Soup… It’s Not Worth Saving.”
- “88% of DCIS is Overtreated.” — A Breast Surgeon Explains the Evidence
- Yes to QT Imaging! Yes to Safer Breast Screening! Yes to Preventing DCIS Overdiagnosis & Overtreatment! Yes to Nutrition & Holistic Wellness!
- CheatSheet — Stay Healthy & Avoid DCIS (“Stage Zero Breast Cancer”) Overdiagnosis & Overtreatment
Top Posts & Pages
- Why DCIS 411?
- Breast Wellness Checklist
- Donna's Journey
- Safe Breast Screening Alternatives
- Contact
- DCIS Controversies
- NO Informed Consent -- Harmed by 5 Titanium Clips in Breast -- DCIS Patient Shares Her Story and Advocacy
- Stories
- In 2011, My Doctor Told Me: "Your Breast is Like Spoiled Soup... It's Not Worth Saving."
- "88% of DCIS is Overtreated." -- A Breast Surgeon Explains the Evidence
Archives
-
Tag Archives: Oncotype DX
BS stands for Blue Shield
Dr. Esserman ordered the Oncotype DX Test for me over 1 month ago (see post “What is Oncotype DX?”) Today I received Blue Shield’s denial letter stating: “A physician advisor has reviewed the information provided and determined that the requested service … Continue reading →
Posted in Options, Personal Stories, Resources
|
Tagged breast cancer treatment, denial letter, gene expression profiling, Oncotype DX
|
4 Comments
What Is Oncotype DX?
Oncotype DX is the first clinically validated commercial genomic assay for patients with DCIS. Oncotype DX reveals the underlying biology that can help guide DCIS treatment decisions by predicting the risk of any local recurrence of breast cancer (DCIS or … Continue reading →